This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignees: Shaanxi University of Science and Technology, Shaanxi Panlong Pharmaceutical Co., Ltd., Xixian New District Fenghou Original Pharmaceutical Technology Co., Ltd.. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 109 
2 out of 5 
1 out of 1 Years Active: 2023-2026
Title: The Innovative Contributions of Yuting Liu in Medicinal Chemistry
Introduction: Yuting Liu, an accomplished inventor based in Xi'an, China, has made significant strides in the field of medicinal chemistry. With a total of two patents to his name, Liu's work focuses on the development of compounds aimed at inhibiting viral activities, particularly those related to coronavirus.
Latest Patents: Liu's latest patents demonstrate his commitment to tackling pressing health challenges. The first, titled "3-tetrazolylmethyl-1,3,5-triazin-2,4-dione compound inhibiting coronavirus 3CL protease activity and preparation method and use thereof," introduces a compound designed to inhibit the SARS-CoV-2 3CL protease activity. This compound represents a potential breakthrough in creating effective SARS-CoV-2 inhibitors, thereby playing a key role in combating the COVID-19 pandemic.
The second patent, "3-triazolyl methyl-1,3,5-triazine-2,4-dione compounds and preparation method and application thereof," also showcases Liu's inventive prowess. This patent discloses a compound that contains multiple structural variations aimed at enhancing the pharmacological efficacy against viral replication and transcription.
Career Highlights: Over the course of his career, Yuting Liu has worked with notable companies such as Shaanxi Panlong Pharmaceutical Co., Ltd. and Xixian New District Fenghou Original Pharmaceutical Technology Co., Ltd. His contributions to these organizations reflect his dedication to innovation in pharmaceutical technology and drug development.
Collaborations: Liu's innovative journey has seen him collaborate with distinguished individuals in the field, including colleagues Chengyuan Liang and Liang Xin. These partnerships have likely facilitated the exchange of ideas and enhanced the development of effective therapeutic agents.
Conclusion: Yuting Liu stands out as a proactive inventor whose patents are instrumental in addressing critical health issues. Through his research and collaborations, he continues to advance the field of medicinal chemistry, paving the way for new treatments that can potentially save lives amid global health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile